Stanozolol Uses, Dosage, Side Effects and more
Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol is derived from testosterone, and has been abused by several high profile professional athletes.
Stanozolol is a synthetic anabolic-androgenic steroid (AAS), which promotes cell growth (anabolism) and development/maintenance of masculine characteristics (androgenism).
| Trade Name | Stanozolol |
| Availability | Discontinued |
| Generic | Stanozolol |
| Stanozolol Other Names | Androstanazol, Androstanazole, Estanozolol, Stanozolol |
| Related Drugs | Orladeyo, danazol, Firazyr, Haegarda, Ruconest, Berinert, Danocrine, Cinryze, Kalbitor |
| Type | |
| Formula | C21H32N2O |
| Weight | Average: 328.4916 Monoisotopic: 328.251463656 |
| Groups | Approved, Vet approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Stanozolol is an anabolic steroid used to manage hereditary angioedema.
Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema. C1-inhibitor is a protease that inhibits the complement system (part of the innate immune system), a biochemical chain of reactions which assists the body in removing pathogens from the body. Stanozolol may help control attacks of hereditary angioedema. Stanozolol can be administered orally or intramuscularly.
Stanozolol is also used to associated treatment for these conditions: Hereditary Angioedema
How Stanozolol works
Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP).
Stanozolol Cholesterol interaction
[Major] Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels.
These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease.
Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen.
Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
Drug Interaction
Unknown: amphetamine / dextroamphetamine, contained in alcoholic beverages , zolpidem, tadalafil, clomiphene, pancrelipase, cholecalciferol, testosterone, omega-3 polyunsaturated fatty acids, chorionic gonadotropin , ferrous sulfate, escitalopram, metoprolol, brexpiprazole, abacavir / dolutegravir / lamivudine, emtricitabine / tenofovir, diazepam, valacyclovir, sildenafil, cyanocobalamin
Disease Interaction
Major: carcinoma (male), fluid retention, hypercalcemia in breast cancer, hyperlipoproteinemia, liver disease, polycythemia, suppression of clotting factorsModerate: diabetes, hypercalcemiaMinor: thyroid function tests
Half Life
24 hours
